Dear CCP4BB,
The Structural Biology Unit at Novartis Vaccines & Diagnostics (NVD), Siena,
Italy, is seeking a candidate for a 2-year post-doctoral project opportunity.
The SB team is comprised of about 10 members (5 full-time staff plus PhD
students and Undergraduates), with key expertise in Protein Biochemistry,
Molecular Modelling, Electron Microscopy, and X-ray Crystallography. The SB
team has a strong track record of publications describing innovative research
aimed at the design and development of novel protein-based vaccines against
bacterial pathogens that cause infectious disease (please see examples below).
We believe this provides a solid platform to perform publishable post-doctoral
research in a stimulating environment of Applied Science.
Based in the heart of Tuscany, NVD - the fifth largest vaccine producer
worldwide - is a research-oriented company that has developed a wide network of
international academic collaborations, sharing its findings with the global
scientific community. At NVD Siena, funding for Individual ("Marie Curie")
post-doctoral EU Fellowships has been successfully obtained on several previous
occasions. For the 2013 EU FP7 People Call, we are formulating what we hope
will be another winning scientific research project proposal. We are seeking an
excellent candidate with whom to develop and submit this application.
The primary project goal is the structure-based design and optimization of a
novel protein antigen for use in a vaccine against Staphylococcus aureus. The
emergence of S. aureus as one of the most important pathogens causing morbidity
and mortality in humans, and the rapid acquisition of antibiotic resistance,
underlies the increasing need for a preventive staphylococcal vaccine. The core
of the project involves protein biochemistry and structural biology (X-ray
crystallography and/or Electron Microscopy), and these would be the most
desirable core skills in potential applicants. The research proposal also has a
multi-disciplinary flavour and will provide development opportunities for the
candidate to gain experience in immunology and vaccine design, at the forefront
of Research and Development.
Eligibility: the candidate should be an experienced researcher (holds a PhD or
>4 yrs post-graduate experience), can be from within or beyond the EU but
should not have lived in Italy for >12 months in the 3 years immediately prior
to the application deadline (August 14th, 2013).
Informal enquiries for further details can be made to
[email protected]<mailto:[email protected]>
Within Monday 17th June, interested candidates should provide a letter of
introduction and CV to:
Matthew J Bottomley
([email protected]<mailto:[email protected]>), Head
of Structural Biology Unit, Novartis Vaccines & Diagnostics, Siena, Italy.
Timelines:
Strong candidates will be contacted for a telephone interview, in order to
allow completion of the application by mid-July.
Application results are expected in Nov/Dec 2013, enabling the successful
candidate to begin work in Siena around Mar/Apr 2014.
Thank you for considering this opportunity!
Yours sincerely,
Matthew Bottomley
A selection of relevant publications from NVD:
1) Malito E et al. "Defining a protective epitope on factor H binding protein,
a key meningococcal virulence factor and vaccine antigen." Proc Natl Acad Sci U
S A (2013).
2) Mariotti P et al. "Structural and functional characterization of the
Staphylococcus aureus virulence factor and vaccine candidate FhuD2." Biochem J.
(2013).
3) Mishra RP et al "Staphylococcus aureus FhuD2 is involved in the early phase
of staphylococcal dissemination and generates protective immunity in mice". J
Infect Dis. (2012).
4) Scarselli M et al "Rational design of a meningococcal antigen inducing broad
protective immunity." Sci Transl Med. (2011).
5) Spraggon G et al "Supramolecular organization of the repetitive backbone
unit of the Streptococcus pneumoniae pilus." PLoS One (2010).
Matthew J Bottomley PhD
Head of Structural Biology Unit
Novartis Vaccines, Via Fiorentina 1, 53100 Siena, Italy
Tel +39 0577 243244
[email protected]
